Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific MAbs.

L. De Monte, P. Nisticó, R. Tecce, P. Dellabona, M. Momo, L. Tarditi, P. G. Natali, M. Mariani, F. Malavasi

Research output: Contribution to journalArticle

Abstract

This report deals with the use of gene transfer by retrovirus-derived shuttle vectors in a novel model aimed at the generation of hybrid hybridomas secreting bispecific monoclonal antibodies (biMAbs). Following this approach, two genes conferring dominant resistance trait to the neomycine analogue geneticin (G418) and to methotrexate (MTX) respectively, were infected in two established hybridoma lines, each producing a well characterized MAb. The vectors used here were replication-deficient, being dependent on the complementation of helper virus provided by packaging lines. The infection procedure involved co-cultivation of the hybridomas with irradiated packaging cell lines, previously transfected with the vectors and producing the recombinant retroviruses, not inclusive of helper virus in their genome. The packaging lines used were psi2 ecotropic cells made able to produce high titers of virus. Further, the vector pMV7 was carrying G418 resistance while the pSDHT render the cells able to survive MTX. Easy and fast transfer of the dominant selection markers yielded lines of hybridomas to be fused according to the conventional somatic fusions. The resulting double hybridomas were tested for the production of hybrid molecules retaining parental specificity and successively underwent extensive cloning. The purification system featuring the most efficiently between the true biMAbs and the parental immunoglobulins (or other combination products) proved to be HPLC on hydroxylapatite column. The method described above was successful in producing two biMAbs targeting simultaneously molecules expressed on cytotoxic cells (such as CD3 on T-lymphocytes and CD16 on NK cells) and the melanoma-associated antigen Ep2.

Original languageEnglish
Pages (from-to)15-22
Number of pages8
JournalDevelopments in Biological Standardization
Volume71
Publication statusPublished - 1990

Fingerprint

Genetic Vectors
Hybridomas
Retroviridae
Bispecific Antibodies
Helper Viruses
Genes
Product Packaging
Methotrexate
Melanoma-Specific Antigens
Virus Assembly
Dominant Genes
Durapatite
Viral Load
Natural Killer Cells
Immunoglobulins
Organism Cloning
High Pressure Liquid Chromatography
Genome
T-Lymphocytes
Cell Line

ASJC Scopus subject areas

  • Biotechnology

Cite this

Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific MAbs. / De Monte, L.; Nisticó, P.; Tecce, R.; Dellabona, P.; Momo, M.; Tarditi, L.; Natali, P. G.; Mariani, M.; Malavasi, F.

In: Developments in Biological Standardization, Vol. 71, 1990, p. 15-22.

Research output: Contribution to journalArticle

@article{dfdb29e74b6448cb9a1e917595ebe339,
title = "Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific MAbs.",
abstract = "This report deals with the use of gene transfer by retrovirus-derived shuttle vectors in a novel model aimed at the generation of hybrid hybridomas secreting bispecific monoclonal antibodies (biMAbs). Following this approach, two genes conferring dominant resistance trait to the neomycine analogue geneticin (G418) and to methotrexate (MTX) respectively, were infected in two established hybridoma lines, each producing a well characterized MAb. The vectors used here were replication-deficient, being dependent on the complementation of helper virus provided by packaging lines. The infection procedure involved co-cultivation of the hybridomas with irradiated packaging cell lines, previously transfected with the vectors and producing the recombinant retroviruses, not inclusive of helper virus in their genome. The packaging lines used were psi2 ecotropic cells made able to produce high titers of virus. Further, the vector pMV7 was carrying G418 resistance while the pSDHT render the cells able to survive MTX. Easy and fast transfer of the dominant selection markers yielded lines of hybridomas to be fused according to the conventional somatic fusions. The resulting double hybridomas were tested for the production of hybrid molecules retaining parental specificity and successively underwent extensive cloning. The purification system featuring the most efficiently between the true biMAbs and the parental immunoglobulins (or other combination products) proved to be HPLC on hydroxylapatite column. The method described above was successful in producing two biMAbs targeting simultaneously molecules expressed on cytotoxic cells (such as CD3 on T-lymphocytes and CD16 on NK cells) and the melanoma-associated antigen Ep2.",
author = "{De Monte}, L. and P. Nistic{\'o} and R. Tecce and P. Dellabona and M. Momo and L. Tarditi and Natali, {P. G.} and M. Mariani and F. Malavasi",
year = "1990",
language = "English",
volume = "71",
pages = "15--22",
journal = "Developments in Biological Standardization",
issn = "0301-5149",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific MAbs.

AU - De Monte, L.

AU - Nisticó, P.

AU - Tecce, R.

AU - Dellabona, P.

AU - Momo, M.

AU - Tarditi, L.

AU - Natali, P. G.

AU - Mariani, M.

AU - Malavasi, F.

PY - 1990

Y1 - 1990

N2 - This report deals with the use of gene transfer by retrovirus-derived shuttle vectors in a novel model aimed at the generation of hybrid hybridomas secreting bispecific monoclonal antibodies (biMAbs). Following this approach, two genes conferring dominant resistance trait to the neomycine analogue geneticin (G418) and to methotrexate (MTX) respectively, were infected in two established hybridoma lines, each producing a well characterized MAb. The vectors used here were replication-deficient, being dependent on the complementation of helper virus provided by packaging lines. The infection procedure involved co-cultivation of the hybridomas with irradiated packaging cell lines, previously transfected with the vectors and producing the recombinant retroviruses, not inclusive of helper virus in their genome. The packaging lines used were psi2 ecotropic cells made able to produce high titers of virus. Further, the vector pMV7 was carrying G418 resistance while the pSDHT render the cells able to survive MTX. Easy and fast transfer of the dominant selection markers yielded lines of hybridomas to be fused according to the conventional somatic fusions. The resulting double hybridomas were tested for the production of hybrid molecules retaining parental specificity and successively underwent extensive cloning. The purification system featuring the most efficiently between the true biMAbs and the parental immunoglobulins (or other combination products) proved to be HPLC on hydroxylapatite column. The method described above was successful in producing two biMAbs targeting simultaneously molecules expressed on cytotoxic cells (such as CD3 on T-lymphocytes and CD16 on NK cells) and the melanoma-associated antigen Ep2.

AB - This report deals with the use of gene transfer by retrovirus-derived shuttle vectors in a novel model aimed at the generation of hybrid hybridomas secreting bispecific monoclonal antibodies (biMAbs). Following this approach, two genes conferring dominant resistance trait to the neomycine analogue geneticin (G418) and to methotrexate (MTX) respectively, were infected in two established hybridoma lines, each producing a well characterized MAb. The vectors used here were replication-deficient, being dependent on the complementation of helper virus provided by packaging lines. The infection procedure involved co-cultivation of the hybridomas with irradiated packaging cell lines, previously transfected with the vectors and producing the recombinant retroviruses, not inclusive of helper virus in their genome. The packaging lines used were psi2 ecotropic cells made able to produce high titers of virus. Further, the vector pMV7 was carrying G418 resistance while the pSDHT render the cells able to survive MTX. Easy and fast transfer of the dominant selection markers yielded lines of hybridomas to be fused according to the conventional somatic fusions. The resulting double hybridomas were tested for the production of hybrid molecules retaining parental specificity and successively underwent extensive cloning. The purification system featuring the most efficiently between the true biMAbs and the parental immunoglobulins (or other combination products) proved to be HPLC on hydroxylapatite column. The method described above was successful in producing two biMAbs targeting simultaneously molecules expressed on cytotoxic cells (such as CD3 on T-lymphocytes and CD16 on NK cells) and the melanoma-associated antigen Ep2.

UR - http://www.scopus.com/inward/record.url?scp=0025142095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025142095&partnerID=8YFLogxK

M3 - Article

C2 - 2401381

AN - SCOPUS:0025142095

VL - 71

SP - 15

EP - 22

JO - Developments in Biological Standardization

JF - Developments in Biological Standardization

SN - 0301-5149

ER -